Catabolic effects of continuous human PTH (1-38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation

被引:321
作者
Ma, YFL
Cain, RL
Halladay, DL
Yang, XH
Zeng, QQ
Miles, RR
Chandrasekhar, S
Martin, TJ
Onyia, JE
机构
[1] Eli Lilly & Co, Lilly Res Labs, Gene Regulat Bone & Inflammat Res Div, Indianapolis, IN 46285 USA
[2] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
关键词
D O I
10.1210/en.142.9.4047
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Continuous infusion of PTH in vivo results in active bone resorption. To investigate the molecular basis of the catabolic effect of PTH in vivo, we evaluated the role of OPG and RANKL, which are known to influence osteoclast formation and function. Weanling rats fed a calcium-free diet were parathyroidectomized and infused with PTH via an Alzet pump to examine: 1) the changes of serum-ionized calcium and osteoclast number, 2) the expression of OPG/RANKL mRNA and protein, and 3) the expression of osteoblast phenotype bone formation-associated genes such as osteoblast specific transcription factor, osteocalcin, bone sialoprotein, and type I collagen. PTH (1-38) (0.01-20 mug/100 g) continuous infusion for 1-24 h resulted in a dose-dependent increase in serum-ionized calcium in parathyroidectomized rats and a corresponding dose-dependent increase in osteoclast number, indicating an increased bone resorption. At 20 mug/100 g PTH dose level, serum-ionized calcium was 2.1-fold of the vehicle control and not different from the Sham-parathyroidectomized rats, and osteoclast number was 3-fold of the vehicle control and 1.7-fold of the Sham-parathyroidectomized rats. In the distal femur, RANKL mRNA expression was increased (27-fold) and OPG mRNA expression was decreased (4.6-fold). The changes in RANKL, and OPG mRNA levels were rapid (as early as 1 h), dose dependent, and sustained over a 24-h period that was examined. Immunohistochemical evaluation of bone sections confirmed that OPG level was reduced in proximal tibial metaphysis upon PTH infusion. Circulating OPG protein level was also decreased by 32% when compared with the parathyroidectomized control. The expression of genes that mark the osteoblast phenotype was significantly decreased (osteoblast specific transcription factor (2.3-fold), osteocalcin (3-fold), bone sialoprotein (2.8-fold), and type I collagen (5-fold)]. These results suggest that the catabolic effect of PTH infusion in vivo in this well-established resorption model is associated with a reciprocal expression of OPG/RANKL and a co-ordinate decrease in the expression of bone formation-related genes. We propose that the rapid and sustained increase in RANKL and decrease in OPG initiate maintain and favor the cascade of events in the differentiation/recruitment and activation of osteoclasts.
引用
收藏
页码:4047 / 4054
页数:8
相关论文
共 51 条
[1]   Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter [J].
Alvarez, M ;
Long, HY ;
Onyia, J ;
Hock, J ;
Xu, WM ;
Bidwell, J .
ENDOCRINOLOGY, 1997, 138 (01) :482-489
[2]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[3]   Activation of osteocalcin transcription involves interaction of protein kinase A- and protein kinase C-dependent pathways [J].
Boguslawski, G ;
Hale, LV ;
Yu, XP ;
Miles, RR ;
Onyia, JE ;
Santerre, RF ;
Chandrasekhar, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (02) :999-1006
[4]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[5]   THE ANABOLIC EFFECT OF HUMAN PTH(1-34) ON BONE-FORMATION IS BLUNTED WHEN BONE-RESORPTION IS INHIBITED BY THE BISPHOSPHONATE TILUDRONATE - IS ACTIVATED RESORPTION A PREREQUISITE FOR THE IN-VIVO EFFECT OF PTH ON FORMATION IN A REMODELING SYSTEM [J].
DELMAS, PD ;
VERGNAUD, P ;
ARLOT, ME ;
PASTOUREAU, P ;
MEUNIER, PJ ;
NILSSEN, MHL .
BONE, 1995, 16 (06) :603-610
[6]   ANABOLIC ACTIONS OF PARATHYROID-HORMONE ON BONE [J].
DEMPSTER, DW ;
COSMAN, F ;
PARISIEN, M ;
SHEN, V ;
LINDSAY, R .
ENDOCRINE REVIEWS, 1993, 14 (06) :690-709
[7]   Osteoprotegerin and osteoprotegerin ligand mediate the local regulation of bone resorption [J].
Dunstan, CR .
ENDOCRINOLOGIST, 2000, 10 (01) :18-26
[8]   COMPARISON OF THE ANABOLIC EFFECTS OF SYNTHETIC PARATHYROID HORMONE-RELATED PROTEIN (PTHRP) 1-34 AND PTH 1-34 ON BONE IN RATS [J].
HOCK, JM ;
FONSECA, J ;
GUNNESSHEY, M ;
KEMP, BE ;
MARTIN, TJ .
ENDOCRINOLOGY, 1989, 125 (04) :2022-2027
[9]   EFFECTS OF CONTINUOUS AND INTERMITTENT ADMINISTRATION AND INHIBITION OF RESORPTION ON THE ANABOLIC RESPONSE OF BONE TO PARATHYROID-HORMONE [J].
HOCK, JM ;
GERA, I .
JOURNAL OF BONE AND MINERAL RESEARCH, 1992, 7 (01) :65-72
[10]   HUMAN PARATHYROID HORMONE-(1-34) INCREASES BONE MASS IN OVARIECTOMIZED AND ORCHIDECTOMIZED RATS [J].
HOCK, JM ;
GERA, I ;
FONSECA, J ;
RAISZ, LG .
ENDOCRINOLOGY, 1988, 122 (06) :2899-2904